BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis
Crossref DOI link: https://doi.org/10.1186/s12885-015-1954-x
Published Online: 2015-12-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Willaert, Wouter
Van Der Speeten, Kurt
Liberale, Gabriel
Ceelen, Wim